Here, we aim to verify the role of circPTK2 in the malignant behavior and cisplatin resistance in NSCLC and to clarify whether the involvement of circPTK2 in NSCLC function was mediated by miR-942/TRIM16 axis. This evidence concerns the gene TRIM16 and non-small cell lung carcinoma.